14 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18464173 | ANTIBODY PRODUCING NON-HUMAN ANIMALS | WEHBE, ANNE MARIE SABRINA | 1634 | Non-Final OA | Sep 08, 2023 |
| 18460482 | ANTIBODY PRODUCING NON-HUMAN ANIMALS | WEHBE, ANNE MARIE SABRINA | 1634 | Non-Final OA | Sep 01, 2023 |
| 18257528 | TREATMENT OF CANCERS WITH AN ANTIBODY THAT BINDS LGR5 AND EGFR | NICKOL, GARY B | 1643 | Non-Final OA | Jun 14, 2023 |
| 18251832 | MEANS AND METHODS FOR TREATING SUBJECTS WITH ERBB3 MUTATION POSITIVE CANCER | GODDARD, LAURA B | 1642 | Non-Final OA | May 04, 2023 |
| 18308232 | ANTIBODIES THAT MODULATE A BIOLOGICAL ACTIVITY EXPRESSED BY A CELL | OUSPENSKI, ILIA I | 1644 | Non-Final OA | Apr 27, 2023 |
| 18062871 | BINDING MOLECULES THAT MODULATE A BIOLOGICAL ACTIVITY EXPRESSED BY A CELL | MOSELEY II, NELSON B | 1642 | Non-Final OA | Dec 07, 2022 |
| 17926283 | METHODS AND MEANS FOR THE PRODUCTION OF IG-LIKE MOLECULES | BRISTOL, LYNN ANNE | 1643 | Final Rejection | Nov 18, 2022 |
| 17921042 | TREATMENT OF CANCERS WITH AN ANTIBODY THAT BINDS LGR5 AND EGFR | SHUPE, ELIZABETH A | 1643 | Final Rejection | Oct 24, 2022 |
| 17759728 | MEANS AND METHOD FOR MODULATING IMMUNE CELL ENGAGING EFFECTS | ALSOMAIRY, SARAH ABDOALATIF | 1646 | Non-Final OA | Jul 29, 2022 |
| 17755196 | MEANS AND METHODS FOR TREATING SUBJECTS WITH HER2 AND HER3 POSITIVE CANCER | BRISTOL, LYNN ANNE | 1643 | Final Rejection | Apr 22, 2022 |
| 17632181 | TREATMENT OF CANCER WITH A COMBINATION OF AN ANTIBODY THAT BINDS LGR5 AND EGFR AND A TOPOISOMERASE I INHIBITOR | MIDDLETON, DANAYA L | 1674 | Final Rejection | Feb 01, 2022 |
| 17431044 | COMBINATIONS OF BINDING MOIETIES THAT BIND EGFR, HER2 AND HER3 | ALSOMAIRY, SARAH ABDOALATIF | 1646 | Final Rejection | Aug 13, 2021 |
| 17431041 | PRODUCING COMPOSITIONS COMPRISING TWO OR MORE ANTIBODIES | FAUST, AMBER KATHLEEN | 1643 | Non-Final OA | Aug 13, 2021 |
| 16499144 | ERBB-2 TARGETING AGENT AND A BISPECIFIC ANTIBODY WITH ANTIGEN-BINDING SITES THAT BIND AN EPITOPE ON AN EXTRACELLULAR PART OF ERB-2 AND ERBB-3, FOR TREATMENT OF AN INDIVIDUAL WITH AN ERBB-2, ERBB-2/ERBB-3 POSITIVE TUMOUR | FAUST, AMBER KATHLEEN | 1643 | Final Rejection | Sep 27, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial